Aegon/€AGN

1D1W1MYTD1Y5YMAX

About Aegon

Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.
Ticker
€AGN
Sector
Finance
Primary listing
AEX
Employees
12,100

Aegon Metrics

BasicAdvanced
€11B
12.33
€0.62
0.62
€0.42
5.53%

What the Analysts think about Aegon

Analyst ratings (Buy, Hold, Sell) for Aegon stock.
Analyst projections of the future price of Aegon stock.

Bulls say / Bears say

Aegon’s underlying momentum improved in the first half of 2026: operating result rose 9% to €804 million and operating capital generation increased 27% to €416 million. Transamerica’s operating result grew 10% in local currency, supported by stronger life sales and distribution. (Reuters, SEC)
Shareholder returns are becoming a more visible part of the investment case. Aegon raised its second-half 2026 buyback to €350 million and increased the interim dividend by 11% to €0.21 per share, backed by €1.7 billion of holding-company cash capital. (Reuters, SEC)
The sale of Aegon UK to Standard Life for total consideration of £2.0 billion should sharpen the group’s focus on US life insurance and retirement markets. Management says the transaction supports its US strategy while retaining unchanged target growth rates from the adjusted base. (Aegon, SEC)
The planned departure of CFO Duncan Russell creates near-term execution risk as Aegon prepares its US relocation and changes its reporting framework. Shares fell about 3% after the announcement, and analysts cited uncertainty around the succession. (Reuters)
The US growth push is not risk-free: policyholder-behaviour and other assumption changes created sizeable charges, while rapid sales growth carried elevated new-business strain. Group solvency also fell to 169% from 184% at year-end 2025, partly because of capital actions and adverse market effects. (SEC, Simply Wall St)
Aegon is executing several major changes at once: selling the UK business, implementing US GAAP and seeking approval for its US redomiciliation. The UK disposal is not expected to close until around year-end 2026 and remains subject to regulatory approval, leaving scope for timing, cost and transition risk. (Aegon, SEC)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.

Aegon Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Aegon Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Aegon

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.